.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Baxter
Cipla
Johnson and Johnson
Colorcon
Daiichi Sankyo
US Army
UBS
US Department of Justice

Generated: January 22, 2018

DrugPatentWatch Database Preview

Drug Master Files for: eprosartan

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
15475III5/29/2001LONZA LTDEPROSARTAN
16703III7/14/2003DISHMAN PHARMACEUTICALS AND CHEMICALS LTDEPROSARTAN MESYLATE
16790III8/22/2003LONZA LTDEPROSARTAN MESYLATE (ROUTE F)
18079AII2/9/2005LONZA AGEPROSARTAN MESYLATE (ROUTE F1)
18155AII3/7/2005DISHMAN CARBOGEN AMCIS LTDEPROSARTAN MESYLATE
22863AII8/31/2009JUBILANT GENERICS LTDEPROSARTAN MESYLATE
23274AII11/17/2009HETERO DRUGS LTDEPROSARTAN MESYLATE
23790AII4/30/2010GLOCHEM INDUSTRIES LTDEPROSARTAN MESILATE
23834AII6/3/2010UNICHEM LABORATORIES LTDEPROSARTAN MESYLATE
24009AII7/29/2010MYLAN LABORATORIES LTDEPROSARTAN MESYLATE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Fuji
Covington
McKinsey
Cerilliant
Citi
Merck
Fish and Richardson
QuintilesIMS
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot